Bardelli; Alberto

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bardelli; Alberto.The latest application filed is for "inactivation of dna repair as an anticancer therapy".

Company Profile

2.12.23

Bardelli; Alberto - Torino IT
Bardelli; Alberto - Turin IT
Bardelli; Alberto - Baltimore MD US
Bardelli; Alberto - I-10132 Turin IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inactivation Of Dna Repair As An Anticancer Therapy App 20210275630 - Bardelli; Alberto ; et al.	2021-09-09
Methods Of Treating Cancer Based On Identifying Mutations In The Extracellular Domain Iii Of Epidermal Growth Factor Receptor Gene App 20210262037 - BARDELLI; Alberto ; et al.	2021-08-26
Method of treating cancer based on identifying mutations in the extracellular domain III of epidermal growth factor receptor gene Grant 11,015,225 - Bardelli , et al. May 25, 2	2021-05-25
Tyrosine kinome Grant 9,926,606 - Bardelli , et al. March 27, 2	2018-03-27
Mutations In The Extracellular Domain Iii Of Epidermal Growth Factor Receptor Gene App 20170260250 - BARDELLI; Alberto ; et al.	2017-09-14
Kras Mutations And Resistance To Anti-egfr Treatment App 20170198353 - Bardelli; Alberto ; et al.	2017-07-13
P13K pathway mutations in cancer Grant 9,580,750 - Parsons , et al. February 28, 2	2017-02-28
Methods Of Treating Patients Having Mutations In The Extracellular Domain Of Epidermal Growth Factor Receptor (egfr) With A Combination Of Three Fully Human Monoclonal Anti-egfr Antibodies App 20160311908 - ARENA; Sabrina ; et al.	2016-10-27
Tyrosine Kinome App 20160160292 - Bardelli; Alberto ; et al.	2016-06-09
Kras Mutations And Resistance To Anti-egfr Treatment App 20160095920 - Bardelli; Alberto ; et al.	2016-04-07
MLK4 gene, a new diagnostic and prognostic marker in cancers Grant 9,127,319 - Bardelli , et al. September 8, 2	2015-09-08
Kras Mutations And Resistance To Anti-egfr Treatment App 20140134158 - Bardelli; Alberto ; et al.	2014-05-15
Tyrosine Kinome App 20130157299 - BARDELLI; Alberto ; et al.	2013-06-20
Mlk4 Gene, A New Diagnostic And Prognostic Marker In Cancers App 20130136755 - Bardelli; Alberto ; et al.	2013-05-30
Tyrosine kinome Grant 8,394,598 - Bardelli , et al. March 12, 2	2013-03-12
Isogenic Human Cell Lines Comprising Mutated Cancer Alleles And Process Using The Cell Lines App 20120115896 - Bardelli; Alberto ; et al.	2012-05-10
K-ras and B-raf mutations and anti-EGFr antibody therapy App 20110212456 - SIENA; Salvatore ; et al.	2011-09-01
P13k pathway mutations in cancer App 20110059434 - Parsons; Donald William ; et al.	2011-03-10
Tyrosine Kinome App 20100184100 - Bardelli; Alberto ; et al.	2010-07-22
Phosphatase associated with metastasis Grant 7,745,165 - Vogelstein , et al. June 29, 2	2010-06-29
Epidermal growth factor receptor gene copy number Grant 7,635,570 - Siena , et al. December 22, 2	2009-12-22
Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues App 20090269344 - Siena; Salvatore ; et al.	2009-10-29
K-ras and B-raf mutations and anti-EGFr antibody therapy App 20090075267 - SIENA; Salvatore ; et al.	2009-03-19
Epidermal growth factor receptor gene copy number App 20070087394 - Siena; Salvatore ; et al.	2007-04-19
Tyrosine kinome App 20070037150 - Bardelli; Alberto ; et al.	2007-02-15
Phosphatase associated with metastasis App 20050047996 - Vogelstein, Bert ; et al.	2005-03-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.